SURMOUNT-1 (Obesity without T2D) The SURMOUNT-1 trial was a landmark study that enrolled 2,539 participants with obesity or overweight (but without T2D) and at least one weight-related comorbidity
Explore other products Sermorelin Injection Summary: Restorative Sleep Hormone Signaling Energy Support B12 (Methylcobalamin) Injection Summary: Energy Metabolism Nervous System Support Cellular Vitality NAD+ Injection Summary: Energy Support Cognitive Resilience Cellular Maintenance NAD+ Nasal Spray Summary: Energy Support Cognitive Function Cellular Repair Sermorelin Capsules Summary: Restorative Sleep Hormone Signaling Energy Support Glutathione Injection Summary: Antioxidant Support Cellular Defense Skin Radiance Methylene Blue Summary: Cognitive Function Oxidative Stress Mitochondrial Health Thymosin Alpha-1 Injection Summary: Immune Support Cellular Longevity Physical Recovery Semax Nasal Spray Summary: Brain Function Cognitive Longevity Emotional Balance Selank Nasal Spray Summary: Calm Support Mental Clarity Emotional Balance KLOW Injection Summary: Tissue Repair Systemic Recovery Inflammatory Balance Dihexa Summary: Memory Power Cognitive Protection Brain Repair Get the latest updates and exclusive offers by subscribing to our newsletter
Diarrhea affected 13-16% of patients with diabetes and up to 30% in obesity trials, while vomiting occurred in 5-9% of those treated with tirzepatide for diabetes and up to 24% in obesity studies
"Cardi B on Feeling Like Lizzie McGuire, Taking Risks in Fashion, and What She and Bernie Sanders Have in Common"
Weight loss outcomes can vary significantly from person to person
Oral glutathiones effects may be slower or inconsistent, while IV glutathione works immediately but requires a clinical setting
